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Sununary The activity of enzymatic defences against free radical attack including superoxide dismutase
(SOD), catalase, glutathione peroxidase and glutathione reductase have been compared in some experimental
animal tumours with the corresponding normal mouse tissues. The activity of SOD in PC6 plasmacytoma and
P388 lymphocytic leukaemia was lower than in normal lymphocytes and the activity in a mouse bladder
carcinoma (MB) was one-half of that of the normal bladder tissue. Similarly PC6, P388, TLX5 lymphoma
and MB showed lower catalase activity than the corresponding normal tissues. The activity of glutathione
peroxidase in tumours was in general comparable with that of the normal tissues with the exception of MB,
while TLX5, PC6 and P388 contained much lower glutathione reductase activity than normal lymphocytes.
The results suggest that it may be possible to selectively destroy certain tumours by peroxidative attack, and
that P388 leukaemia would be much more sensitive than L1210 leukaemia to free radical production.
A differential cytotoxic effect towards tumour cells
may be possible based on a reduced ability to
detoxify free radicals. Free radicals and in particular
superoxide radical (02--) cause cellular disruption
due to peroxidation of membrane lipids. Several
enzymes have evolved to cope with 02- produced
by metabolic reactions in cells in an oxygen
environment. (a) Superoxide dismutase (SOD) which
converts 02 to H202 and °2- (b) Catalase which
serves to reduce the H202 to H20. (c) Glutathione
peroxidase which acts complementarily to catalase
in elimination of H202 especially in tissues or
compartments devoid of catalase. (d) Glutathione
reductase which catalyzes the reduction of the
oxidized form of glutathione produced by
glutathione peroxidase by reduced pyridine
nucleotides.
Some deficiencies in these free radical
detoxification enzymes have been shown in tumour
tissues. Diminished amounts of manganese-
containing SOD have been found in all tumours
examined to date (Oberley & Buettner, 1979). Also,
lowered amounts of copper-zinc-containing SOD
have been found in many, but not all tumours
(Oberley et al., 1978; Yamanaka et al., 1978). At the
same time mitochondrial fragments from Ehrlich
ascites tumour cells had nearly the same rate of
superoxide formation as bovine heart, while the
mitochondrial fragments from Morris hepatoma
had nearly a 5-times higher rate (Dionisi et al.,
1975). This could result in a net increase in the level
of superoxide ion in the tumour cell. Paraquat, a
herbicide that increases intracellular production of
superoxide ion was 4-times more toxic to virus
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transformed rat kidney cells than the corresponding
untransformed kidney cells (Fernandez-Pol et al.,
1982). There was a good correlation between the
susceptibility of transformed and untransformed
cells to paraquat cytotoxicity and their ability to
increase SOD activity.
The glutathione peroxidase activity in hepatomas
has been shown to be much lower than that of
normal liver (Pinto & Bartley, 1973). The activity of
catalase is also lower in hepatomas than in normal
liver (Ono, 1966). These results suggest that the
activities of enzymes involved in the formation and
utilization of hydroperoxides in hepatomas may be
decreased.
This study compares the total cellular activity of
SOD, catalase, glutathione peroxidase and
glutathione reductase in experimental animal
tumours of peripheral tissues with that found in
normal host tissues, some of which are susceptible
to the cytotoxicity of current chemotherapeutic
agents, as a preliminary investigation of the ability
of neoplastic tissues to deal with free radical attack.
Materials and methods
All chemicals were reagent grade and were
purchased from Sigma Chemical Co., Dorset.
Tumours
The transplantable animal tumours used in this
study were the PC6 plasma-cytoma transplanted i.p.
into Balb/c mice, P388 murine lymphocytic
leukaemia and L1210 murine lymphocytic
leukaemia transplanted i.p. into BDF1 mice, and
the TLX5 lymphoma passaged i.p. in CBA/CA
mice. Other tumours were maintained in tissue
culture in Dulbecco's modified Eagles medium
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containing 10% foetal calf serum under an
atmosphere of 10% CO2 in air. These were Walker
rat carcinoma 256 (W256), a mouse bladder
carcinoma (MB), and a human erythroleukaemia
cell line (K562). Two normal epithelial cell line,
L132, human embryonic lung and D98, normal
sternal bone marrow, were purchased from Gibco,
Europe and were used as a comparison of the effect
of culture conditions on enzyme activity.
Determination ofenzyme activity
Mouse tissues were excised, weighed and rapidly
homogenized in 2 volumes of ice-cold 50mM
phosphate, pH 7.0. The homogenate was then
sonicated at 4°C for 10-20sec at 125W using an
MSE sonic oscillator. The supernatant obtained
after centrifugation at 18,000g for 20min was used
for the determination of enzyme activity. Tumour
cells after extensive washing in 0.9% NaCl were
processed as for normal tissues. Lymphocytes were
isolated from a spleen preparation by a
modification of the method of Boyum (1968).
Enzyme activity is expressed as a function of total
cellular protein which was determined by the
method of Lowry using bovine serum albumin as a
standard.
Superoxide dismutase
The standard method of Beauchamp & Fridovich
(1971) was used. A flux of superoxide was generated
by the action of xanthine oxidase on xanthine, and
nitro blue tetrazolium (NBT) was used to detect this
radical. The reduction of formazan formation was
used as the basis of the assay for SOD. One unit of
SOD is defined as that amount of enzyme that will
inhibit the reduction of NBT by xanthine oxidase
by 50% under the assay conditions. A calibration
curve was constructed using commercially-prepared
SOD.
Catalase
The decrease in absorption of H202 at 240nm due
to the action of catalase was used as a basis for the
determination of enzyme activity. One unit is
defined as that amount of enzyme which liberates
half the peroxide oxygen from a 12.5mM solution
of H202 in 100sec at 25°C.
Glutathione peroxidase
Enzyme activity was determined by a modified
procedure of Pinto & Bartley (1969). Oxidized
glutathione was converted to the reduced form with
glutathione reductase and NADPH. The decrease in
absorbance at 340nm was used as a measure of
enzyme activity. One unit of glutathione peroxidase
is defined as the number of micromoles of NADPH
oxidized per min calculated on the basis of the
molar absorptivity for NADPH at 340nm of
6.22 x 103mol-1 cm-1.
Glutathione reductase
Enzyme activity was determined by monitoring the
oxidation of NADPH at 340nm using the method
of Worthington & Rosemeyer (1974). The assay
mixture contained 0.2M KC1, 1 mM EDTA, 1 mM
oxidized glutathione (GSSG) in 0.1mM phosphate,
pH 7.0. The reaction was initiated by the addition
of NADPH to a final concentration of 0.1 mM. One
unit of glutathione reductase activity is defined as
that amount of enzyme which catalyzes the
oxidation of 1pmol NADPH min-1 under the
above conditions.
Results
The SOD activity in normal mouse tissues and
experimental tumours is shown in Table I. As
Table I Superoxide dismutase and catalase activity in
normal andtumour tissue
Specific activity
(units mgprotein 1)± s.e.*
Tissue SOD Catalase
Liver 196+2 36.0+0.5
Kidney 173±3 16.6+0.3
Brain 134±9 0.5+0.01
Intestine 116+4 0.7+0.04
Heart 105+1 1.8+0.05
L132 102±3 1.4+0.03
D98 97+2 0.9±0.02
Bladder 97+3 0.7+0.01
Lymphocytes 74+1 0.6+0.04
L1210 92±1 0.9+0.01
TLX5 71+0.7 0.4±0.01
MB 45+0.5 0.3±0.01
W256 42+0.4 0.5+0.04
K562 39+0.2 0.3+0.02
P388 28+0.5 0.4+0.01
PC6 12+0.4 0.3+0.03
*Mean of 3 determinations on separate occasions.
reported by others (Crapo and Tierney, 1974) liver
was found to have the highest specific activity of
SOD followed by kidney, brain, intestine and heart.
The activity of SOD in lymphocytes was found to
be the lowest amongst the normal tissues and the
activity in 2 lymphocytic tumour cell lines, L1210
and TLX5 was not significantly different fromFREE RADICAL DETOXIFYING ENZYMES 811
normal lymphocytes. However, PC6 plasmacytoma
and P388 lymphocytic leukaemia were found to
possess much lower SOD than normal lymphocytes.
The activity of SOD in a mouse bladder carcinoma
(MB) was only one-half of that of the corresponding
normal bladder tissue. Also, the activity in an
epithelial tumour in vitro (W256) was much lower
than that found in normal epithelial cell lines (L132
and D98).
The specific activity of catalase in various normal
and tumour tissues is also shown in Table I. Liver
and kidney again showed the highest levels of
enzyme activity, while other normal tissues were
found to contain a relatively lower level of catalase
activity, especially in brain and lymphocytes. The
specific activity of catalase in the tumours studied
was in general much lower than that of the normal
tissues. Three lymphocytic tumours, PC6, P388 and
TLX5 contained a lower enzyme level (0.28, 0.41
and 0.43umg-1 protein respectively) than normal
lymphocytes (0.58umg-1 protein) while the activity
in L1210 leukaemia (0.93 umg-' protein) was much
higher than in normal lymphocytes. The catalase
activity in the mouse bladder carcinoma
(0.32umg-' protein) was only one-half of that of
normal bladder (0.67umg-1 protein).
Both liver and kidney displayed high levels of
glutathione peroxidase activity (Table II) while
other normal tissues were found to contain
relatively lower enzyme activity (0.23-0.075 of liver).
In general the tumours displayed activity
comparable with that of normal tissues with the
Table II Glutathione peroxidase and glutathione
reductase activity in normal and tumour tissues
Specific activity
(units mgprotein-1)±s.e.*
Glutathione Glutathione
Tissue peroxidase reductase
Liver 0.34 +0.03 0.043 +0.004
Kidney 0.19 +0.02 0.056 +0.006
Intestine 0.08 +0.008 0.033 +0.006
Brain 0.03 +0.003 0.028 +0.004
Lymphocytes 0.025 +0.002 0.018 +0.002
L132 0.15 +0.01 0.016 +0.003
Bladder 0.05 +0.005 0.012 +0.001
D98 0.055 +0.005 0.012 +0.001
L1210 0.025 +0.003 0.0185+0.002
K562 0.021 +0.002 0.181 +0.002
TLX5 0.025 +0.003 0.0123+0.003
W256 0.021 +0.004 0.0123+0.002
MB 0.021 +0.002 0.011 +0.001
PC6 0.018 +0.002 0.010 ±0.001
P388 0.0175+0.003 0.009 +0.001
*Mean of 3 determinations on separate occasions.
exception of MB (0.021 umg-1 protein) which had
much lower activity than normal mouse bladder
(0.05umg-' protein).
Glutathione reductase activity was also highest in
kidney and liver (Table II). Among the lymphocytic
leukaemias the activity in L1210 leukaemia
(0.019 umg' protein) was similar to that of normal
lymphocytes (0.018 umg-1 protein) while TLX5
lymphoma, PC6 plasmacytoma and P388 leukaemia
contained much lower glutathione reductase activity
(0.012, 0.010 and 0.009umg-' protein respectively).
The activity in MB was comparable with that of
normal bladder.
Discussion
This study attempts to compare the level of
enzymatic defences against free radical attack in
some representative experimental tumours with
normal host tissues. A major problem with the
investigation of any biochemical parameter in
tumours is a lack of knowledge of the cell of origin
for comparison. Four lymphocytic tumours have
been compared with the total spleen lymphocyte
population and a mouse bladder carcinoma with
normal mouse bladder. The enzyme values for other
normal tissues have also been included to put these
results in perspective. The study demonstrates the
heterogeneity which occurs amongst different
tumour populations. Thus, while P388 murine
lymphocytic leukaemia contains lower levels of
SOD, catalase, glutathione peroxidase and
glutathione reductase than normal lymphocytes,
enzyme levels in L1210 murine lymphocytic
leukaemia are in each case comparable with that of
the normal population. The most general
conclusions are a decrease in both SOD and
catalase in most of the tumours studied, while the
changes in glutathione peroxidase and glutathione
reductase are more variable. In no case was there a
complete loss of enzyme activity in any of the
neoplastic tissues as previously reported for Cu-Zn
and Mn-SOD (Oberley & Buettner, 1979), although
the relative deficiency of SOD and catalase could
result in decreased detoxification of 02'- in
tumours. This could result in cell death from
membrane damage arising from peroxidative
reactions of polyunsaturated fatty acids (lipid
peroxidation) and attack of reactive oxygen species
on proteins and nucleic acids.
It is interesting to note that many of the drugs
currently in use in cancer chemotherapy are
activated to radical intermediates. Thus superoxide
radical is one of the mediators for the enhancement
of the chain breakage action of bleomycin (Ishida &
Takahashi, 1975), the toxicity of the aziridinyl812 M.J. TISDALE & M.B. MAHMOUD
quinone 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-
1,4-benzo-quinone (Gutierrez et al., 1982) and the
cardiotoxicity of adriamycin (Olson et al., 1981). In
an aerobic system the redox cycling of mitomycin C
results in oxygen-dependent lipid peroxidation
(Trush et al., 1982). It might be expected that such
agents would be more toxic towards a tumour
deficient in free radical detoxification mechanisms
such as P388 leukaemia. Studies at the National
Cancer Institute, U.S.A. (Goldin et al., 1981) show
P388 leukaemia to be more sensitive than L1210
leukaemia towards mitomycin C, daunomycin,
bleomycin and neocarzinostatin, a protein antibiotic
considered to act by a free radical mechanism
(Favaudon, 1982). The results presented suggest that
it may be possible to design other agents which
selectively generate free radicals in some tumours.
This work has been supported by a grant from the Cancer
Research Campaign.
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